COVID-19
The Philippine government has assured healthcare workers that they will remain a top priority in the country's COVID-19 vaccination campaign, with all Covid vaccines delivered from March to April to be specifically allocated to them. According to vaccine czar Carlito Galvez Jr., the government aims to vaccinate 2
COVID-19
As the Public Health Agency of Canada gears up for a massive vaccine distribution effort, the country's spending on COVID-19 treatments and vaccines has reached unprecedented heights. With a federal budget of up to $5 billion, the Agency is working to ensure continuity of funding to match the
COVID-19
The global respiratory diseases drugs market is expected to decline in 2021, due to the stabilization of output by companies after the COVID-19 pandemic in 2020. However, the market is expected to recover and reach $98.81 billion by 2025 at a compound annual growth rate (CAGR) of 5%. Companies
COVID-19
The Biden administration's first military action has been launched in Syria, targeting Iranian-backed militia groups in response to a rocket attack that killed a civilian contractor and wounded a U.S. service member. Vaccination efforts continue to show significant progress, with Pfizer and Moderna anticipating providing 220 million
COVID-19
Despite a decline in infections, experts warn of a potential surge in cases due to highly contagious variants, such as the B.1.1.7 variant first detected in the UK. Trevor Bedford from the University of Washington and the Fred Hutchinson Cancer Research Center predicts a wave in April
COVID-19
The global economy is bracing for a sudden rise in inflation due to massive economic stimulus packages and ultra-loose monetary policy. However, the US Federal Reserve's minutes suggest a more optimistic outlook for the US economy. Surprisingly robust consumer climate in the US retail sector and positive news
COVID-19
Pregnant women and breastfeeding mothers are among those who will be offered the Pfizer COVID-19 vaccine from Monday, as per a recent announcement by Western Sydney University. This comes after the Therapeutic Goods Administration (TGA) approved the vaccine for individuals aged 16 and older, with the federal health department providing
COVID-19
The VEGF inhibitor market is experiencing a decline due to the COVID-19 pandemic, but it is expected to recover and grow significantly in the coming years. The market was valued at $0.31 billion in 2019 and is projected to reach $1.72 billion by 2023 at a compound annual
COVID-19
South Africa is racing to adjust its COVID-19 vaccination strategy after preliminary data suggested the AstraZeneca vaccine may be only minimally effective against the country's dominant variant, prompting the suspension of its use among health workers. The country is now weighing the option of giving Johnson & Johnson&
COVID-19
The COVID-19 pandemic has led to a decline in the anti-Parkinson drugs market, with a projected CAGR of -2.62% in 2020. However, the market is expected to recover and reach $5.04 billion in 2023 at a CAGR of 7.01%. The market is driven by increasing investments in
COVID-19
The COVID-19 pandemic's impact on the global economy continues to recede, with the number of Americans who have received at least one vaccine dose matching the number of those who have tested positive over the past year. The ease in market volatility, driven by a decrease in retail
COVID-19
US President Joe Biden has set a goal to administer 1.5 million COVID-19 vaccinations daily, while Pfizer aims to deliver vaccine doses faster than expected. Johnson and Johnson expects to have details on its COVID-19 vaccine trial next week. The company has filed for emergency use authorization with the
